IntriCon Announces Offering of 700,000 Shares of Common Stock
May 12 2016 - 6:07PM
Business Wire
IntriCon Corporation (NASDAQ: IIN) (the “Company”) announced
today that it has commenced an underwritten public offering of
700,000 shares of its common stock. All of the shares in the
proposed offering are to be sold by the Company.
Dougherty & Company LLC is the sole underwriter of the
offering. The Company expects to grant the underwriter a 30-day
option to purchase up to an additional 105,000 shares of its common
stock. The offering is subject to market and other conditions, and
there can be no assurance as to whether or when the offering may be
completed, or as to the actual size or terms of the offering.
The Company intends to use the net proceeds from the offering
for working capital and general corporate purposes.
A shelf registration statement on Form S-3 relating to the
public offering of the shares of common stock described above was
filed with the Securities and Exchange Commission (the “SEC”) and
is effective. A preliminary prospectus supplement relating to the
offering has been filed with the SEC. Copies of the preliminary
prospectus supplement and accompanying base prospectus may be
obtained at the SEC’s website at www.sec.gov or from Dougherty
& Company LLC, Attention: Joseph Sullivan, Corporate Finance
and Investment Banking, 90 South 7th Street, Suite 4300,
Minneapolis, MN 55402, or toll free at (800) 328-4000.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the shares described herein or any
other securities, nor shall there be any sale of these shares in
any state or other jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification
under the securities laws of such state or other jurisdiction. The
offering may be made only by means of a prospectus supplement and
the accompanying base prospectus.
About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation
designs, develops and manufactures miniature and micro-miniature
body-worn devices. These advanced products help medical, healthcare
and professional communications companies meet the rising demand
for smaller, more intelligent and better connected devices.
IntriCon has facilities in the United States, Asia, United Kingdom
and Europe. The company’s common stock trades under the symbol
“IIN” on the NASDAQ Global Market. For more information about
IntriCon, visit www.intricon.com.
Forward-Looking Statements
Statements made in this release and in IntriCon's other public
filings and releases that are not historical facts or that include
forward-looking terminology are "forward-looking statements" within
the meaning of the Securities Exchange Act of 1934, as amended.
These forward-looking statements may be affected by known and
unknown risks, uncertainties and other factors that are beyond
IntriCon's control, and may cause IntriCon's actual results,
performance or achievements to differ materially from the results,
performance and achievements expressed or implied in the
forward-looking statements. These risks, uncertainties and other
factors are detailed from time to time in the company's filings
with the Securities and Exchange Commission, including the Annual
Report on Form 10-K for the year ended December 31, 2015. The
company disclaims any intent or obligation to publicly update or
revise any forward-looking statements, regardless of whether new
information becomes available, future developments occur or
otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160512006628/en/
At IntriCon:Scott Longval, CFO,
651-604-9526slongval@intricon.comorAt PadillaCRT:Matt
Sullivan, 612-455-1709matt.sullivan@padillacrt.com
Intricon (NASDAQ:IIN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intricon (NASDAQ:IIN)
Historical Stock Chart
From Apr 2023 to Apr 2024